Trial aims to personalize and improve Pre-Surgery breast cancer treatment

NCT ID NCT05900206

Summary

This study is comparing a newer drug, trastuzumab deruxtecan (T-DXd), to the standard pre-surgery treatment for people with non-metastatic HER2-positive breast cancer. About 370 participants will be randomly assigned to receive either the new drug or the standard treatment for three cycles. The main goal is to see if the new drug is more effective at eliminating cancer from the breast and lymph nodes before surgery, and to find markers in the tumor or blood that might help predict which treatment works best for each person.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Karolinska University Hospital

    RECRUITING

    Stockholm, 17164, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Norrlands University Hospital

    NOT_YET_RECRUITING

    Umeå, 90185, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sankt Gorans Hospital

    NOT_YET_RECRUITING

    Stockholm, 11219, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Skåne University Hospital

    NOT_YET_RECRUITING

    Malmo, 21428, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Stockholm Southern Hospital

    NOT_YET_RECRUITING

    Stockholm, 11861, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Uppsala University Hospital

    NOT_YET_RECRUITING

    Uppsala, 75185, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Örebro University Hospital

    NOT_YET_RECRUITING

    Örebro, 70185, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.